PF-04457845 is a potent and selective FAAH inhibitor, exhibiting high efficacy against both human (IC50=7.2 nM) and rat (IC50=7.4 nM) enzymes. It is a valuable research tool for studying endocannabinoid signaling in preclinical models of pain, inflammation, and neurological disorders.